Improved local delivery of TGF-β2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol

Journal of Biomedical Materials Research

Volumn 39, Issue 4, 1998, Pages 539-548

  Bentz, H ^a   Schroeder, J A ^a   Estridge, T D ^a  

^a ALLERGAN INC   (United States)

Author keywords

Biomaterials; Collagen; Cytokine delivery via covalent binding; Polyethylene glycol; Tissue repair; Transforming growth factor

Indexed keywords

ANTIBODIES; BIOASSAY; COLLAGEN; CONTROLLED DRUG DELIVERY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POLYETHYLENE GLYCOLS; TISSUE;

COVALENT BINDING; DERMAL FIBRILLAR COLLAGEN; TRANSFORMING GROWTH FACTOR;

IMPLANTS (SURGICAL);

BIOMATERIAL; COLLAGEN IMPLANT; MACROGOL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; COVALENT BOND; CROSS LINKING; DRUG ACTIVITY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; IMMUNOBLOTTING; MALE; NONHUMAN; RAT; SHELF LIFE;

ANIMALS; CATTLE; CELL LINE; COLLAGEN; MALE; MINK; POLYETHYLENE GLYCOLS; PROTEIN BINDING; RATS; SOLUBILITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032521332     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K     Document Type: Article

References (19)

1. J. M. McPherson, D. G. Wallace, and K. A. Piez, "Development and biochemical characterization of injectable collagen," J. Dermatol. Surg. Oncol, 14(Suppl. 1), 13-20 (1988).
2. J. Keefe, L. Wauk, S. Chu, and F. DeLustro, "Clinical use of injectable bovine collagen: A decade of experience," Clin. Mater., 9, 155-162 (1992).
3. G. A. Ksander, Y. Ogawa, G. H. Chu, H. McMullin, J. S. Rosenblatt, and J. M. McPherson, "Exogenous transforming growth factor-beta2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent," Ann. Surg., 211, 288-294 (1989).
4. H. Bentz, A. Y. Thompson, R. Armstrong, R.-J. Chang, K. A. Piez, and D. M. Rosen, "Transforming growth factor-β2 enhances osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3," Matrix, 11, 269-275 (1991).
5. A. B. Roberts, M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, I. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrle, and A. S. Fauci, "Transforming growth factor type-beta: Rapid induction of fibrosis and angiognesis in vivo and stimulation of collagen formation in vitro," Proc. Natl. Acad. Sci. USA, 83, 4167-4171 (1986).
6. R. A. Ignotz and J. Massague, "Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix," J. Biol. Chem., 261, 4337-4345 (1986).
7. Y. Ogawa, S. J. Sawamura, G. A. Ksander, R. M. Armstrong, B. M. Pratt, and J. M. McPherson, "Transforming growth factors-β1 and β2 induce synthesis and accumulation of hyaluronate and chondroitin sulfate in vivo," Growth Factors, 3, 53-62 (1990).
8. M. A. O'Reilly, D. Danielpour, A. B. Roberts, and M. B. Sporn, "Regulation of expression of transforming growth factor-β2 by transforming growth factor beta isoforms is dependent upon cell type," Growth Factors, 6, 193-201 (1992).
9. A. B. Roberts, U. I. Heine, K. C. Flanders, and M. B. Sporn, "Transforming growth factor-β: Major role in regulation of extracellular matrix," Ann. NY Acad. Sci., 580, 225-232 (1990).
10. A. Abuchovski, J. R. Mc Coy, N. C. Palcuzu, T. van Es, and F. F. Davis, "Effect covalent attachment of PEG on immunogenicity of circulating life of bovine liver catalase," J. Biol. Chem., 252, 3578-3586 (1977).
11. S. Zalipsky, R. Seltzer, and S. Menon-Rudolph, "Evaluation of new reagents for covalent attachment of polyethylene glycol to proteins," Biotech. Appl. Biochem., 15, 100-114 (1992).
12. W. Rhee, J. Carlino, S. Chu, and H. Higley, "Bovine collagen modified by PEG," in Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications, J. M. Harris (ed.), Plenum Press, New York, 1992.
13. V. N. Katre, M. J. Knauf, and W. J. Laird, "Chemical modification of recombinant II-2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model," Proc. Natl. Acad. Sci. USA, 84, 1487-1491 (1987).
14. J. R. Dasch, D. R. Pace, W. Waegell, D. Inenaga, and L. Ellingsworth, "Monoclonal antibodies recognizing transforming growth factor beta 2 affinity purification," J. Immunol., 142, 1536-1541 (1989).
15. U. K. Laemmeli, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4," Nature, 227, 680-685 (1970).
16. F. W. Studier, "Analysis of bacteriophage T7 early RNA's and proteins on slab gels," J. Mol. Biol., 79, 237-248 (1973).
17. H. Takiuchi, T. Tada, X.-F. Li, M. Ogata, T. Ikeda, S. Fujimoto, H. Fujiwara, and T. Hamaoka, "Particular types of tumor cells have the capacity to convert transforming growth factor beta from a latent to an active form," Cancer Res., 52, 5641-5646 (1992).
18. D. Danielpour, L. L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn, "Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture," J. Cell. Physiol., 138, 79-86 (1989).
19. R. D. Fields and M. V. Lancaster, "Dual continuous monitoring of cell proliferation/cytotoxicity," Am. Biotechnol. Lab., March, 48-49 (1993).